The medical landscape is undergoing a seismic shift with the rise of GLP-1 (glucagon-like peptide-1) diabetes and weight-loss treatments. Novo Nordisk’s Ozempic and Wegovy, along with Eli Lilly’s Mounjaro, have been at the forefront of this revolution. These treatments, originally developed for managing type-2 diabetes, have shown remarkable efficacy in…
Tag: AZN
AI in Health Care: Revolutionizing Medicine and Investment Opportunities
Artificial Intelligence (AI) is not just another buzzword in the tech industry; it is a transformative force that is reshaping various sectors, particularly health care. From enhancing patient care to streamlining hospital operations, AI is addressing some of the most pressing challenges in health care. But for investors, AI’s integration…